Medivir AB (publ) (STO:MVIR)
Sweden
· Delayed Price · Currency is SEK 1.950
+0.010 (0.52%)
At close: Apr 28, 2026
Medivir AB Revenue
In the year 2025, Medivir AB had annual revenue of 8.51M SEK with 144.14% growth. Medivir AB had revenue of 5.51M in the quarter ending December 31, 2025, with 522.85% growth.
Revenue
8.51M
Revenue Growth
+144.14%
P/S Ratio
123.49
Revenue / Employee
850.60K
Employees
10
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.51M | 5.02M | 144.14% |
| Dec 31, 2024 | 3.48M | -4.15M | -54.36% |
| Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
| Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
| Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xspray Pharma AB | 2.47M |
| Cantargia AB | 316.70M |
| Genovis AB (publ.) | 129.65M |
| BioInvent International AB | 226.50M |
| Infant Bacterial Therapeutics AB | -1.00K |
| FluoGuide | 318.79K |
| Saniona AB | 434.40M |
| Oncopeptides AB | 71.12M |